An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on Mounjaro (a prescription drug for diabetes and weight loss) wrote that after starting the drug in September 2025 they lost almost 25 kg, but around ten weeks ago the weight loss stopped and the "food noise"—constant, intrusive thoughts about food—returned. They can still not eat a lot physically, but they feel mentally preoccupied with food, like a drug craving, and are unsettled by how quiet their thoughts had been before the return of this preoccupation. Mounjaro is the brand name for tirzepatide. It’s a man-made medicine that copies hormones your gut releases after you eat. Those hormones send signals to your brain that reduce appetite and slow how quickly your stomach empties, so you feel full longer. Doctors prescribe it for type 2 diabetes and, increasingly, as a weight-loss treatment. People take it as a weekly injection at doses that are gradually increased. The real-world post describes an individual experience, not a controlled study. Clinical trials of tirzepatide showed many people lose substantial weight and report reduced appetite, especially early on. But the trials also show weight loss can slow or plateau after months, and people vary a lot in how their appetite and cravings change over time. Anecdotal reports like this one emphasize a return of persistent food thoughts even when physical hunger is low. That’s consistent with behavior seen in some patients who experience cognitive or emotional preoccupation with eating despite reduced caloric intake. This matters because medication is just one piece of weight management. For many people, the biggest benefits of drugs like tirzepatide are early appetite suppression, but long-term results often require habits, psychological support, or changes in environment. If the "noise" of constant food thoughts comes back, it can be distressing and make it harder to stick with healthy choices. People using these drugs — or thinking about them — should know that mental cravings can persist or return and that support from clinicians, nutritionists, or mental health professionals can help manage that. Caveats: this is one person’s report. It doesn’t tell us why their weight loss stalled or why the food thoughts returned. Possible explanations include reaching a new steady weight, dose issues, natural adaptation to the drug, stress, changes in sleep or activity, or underlying eating-related behaviors. Side effects of tirzepatide can include nausea, diarrhea, and rare but serious risks like pancreatitis; it’s prescription-only and should be managed by a doctor. Don’t change dose or stop the medication without medical advice. If intrusive food thoughts feel like addiction or cause severe distress, mention it to your clinician — they can adjust treatment or refer for behavioral support. Bottom line: Mounjaro can quiet appetite and produce big early weight loss, but cravings and food-focused thinking can return for some people; talk with your doctor if that happens.
Source: r/Mounjaro